On Tuesday, shares of AstraZeneca Pharma India surged following the announcement of an exciting alliance with Sun Pharmaceutical Industries. Together, they are set to enhance the availability of Sodium Zirconium Cyclosilicate, which combats hyperkalemia. AstraZeneca will introduce this treatment to the market under the name Lokelma, while Sun Pharma will distribute it as Gimliand.

See Full Page